Hide Board Information

Show Board Information

Ecrid, Inc. ECDD

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/26/2022 6:00:07 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 13

Ecrid, Inc. (OTCMRKTS: ECDD) Stock Message Board

1. ECDD Company Profile

    

2. ECDD Time & Sales

    

3. ECDD Recent News

    

4. ECDD Filings

    

5. ECDD Financials

    

6. ECDD Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

10	Ecrid, Inc. ( $ECDD) - FORM 10-Q |	MatthewDavies	08/26/2022 6:00:07 AM
9	NAFEO and ECRID (Stock: $ECDD) join	MatthewDavies	08/25/2022 10:24:26 AM
8	ECDD has seen a robust and	IR_CONSULTING_HEAD	08/24/2022 6:05:54 AM
7	With solid performance on the OTC,	jennifer_john	08/24/2022 5:59:43 AM
6	When do you anticipate some news on this?	Pokerpro05	04/06/2017 10:48:47 AM
5	RMGX TONS OF DD OVER AT INVESTORSHUB THIS COULD	CBD KING	02/13/2017 10:47:15 AM
4	ITS A MERGER FROM BLACK SHOPPING CHANNEL $RMGX	CBD KING	02/13/2017 10:09:13 AM
3	RMGX Financials 07/16/2014 15:19:20 DPOLLUTION	Emylers	07/16/2014 4:19:15 PM
2	RMGX 0.0025 Stock Charts $RMGX 1 Month Chart	chartguy89	03/09/2014 2:06:55 PM
1	RMGX Stock Charts Last: +0.0005 Saturday, March	chartguy89	03/01/2014 9:57:59 AM

Recent Articles

• Harrison Street Celebrates a Decade as Top Money Management Employer
• US National Drone Association Pushes for Strengthened Drone Policies
• The Future of Confidential Computing: Trends and Innovations
• Exploring the Future of the Carbon Dioxide Market Growth
• Innovative Advances in Elritercept Program Highlighted at ASH
• New Developments in Cancer Therapy from Autolus at ASH Meeting
• CARVYKTI®: Pioneering Breakthroughs in Myeloma Treatment
• VERSES Secures $770,000 in Latest Funding Round for Growth
• Update on Imperial Metals: Legal Developments and Future
• CARVYKTI® Breakthrough Results in Multiple Myeloma Study
• Antengene Unveils Late-Stage Study Results of Selinexor
• GATE Energy's Partnership with Shell for Sustainability Project
• ThreeD Capital Inc. Reports November 2024 Net Asset Value Insights
• Sirios Resources Secures $849,000 in Flow-Through Placement
• Seaspan Champions Connectivity with OneWeb Satellite Partnership
• Cassius Ventures Addresses Canada Post Strike Impact on Meetings
• BitRail to Shine at New England Venture Summit Presentation
• Quobly Reaches Major Milestone in Quantum Computing Innovation
• Transformative AI Solutions in Identity Management by AKA Identity
• Exploring the Implications of Interpublic's Acquisition Deal
• Allegations Against Tony Buzbee: Betrayal of Trust and Ethics
• Vera Therapeutics Announces Employee Inducement Awards Details
• Unique Opportunity for Investors with DMC Global Inc. Lawsuit
• Family Pursues Justice Following Fatal Wisdom Teeth Surgery
• Securities Class Action Against Kyverna Therapeutics: What You Need to Know
• Allegiant Air Pilots Teamsters Plan Practice Picket for Rights
• Understanding S&P Dow Jones Indices Liquidity Criteria Changes
• Seaspan Partners with KVH for Enhanced Fleet Connectivity
• Italy's Strategic Energy Role and Libyan Oil Potential Unveiled
• Jackson Acquisition Company II Advances with $200 Million IPO Plans
• Innovation in Eco-Friendly Packaging from American Packaging
• Financial Challenges and Strategic Moves of Husqvarna Group
• Strategic Board Restructuring for Teekay Group Leadership
• Avance Gas Achieves Milestone with Eighth VLGC Delivery
• JPMorgan Chase Announces New Dividend for Shareholders
• MAIA Biotechnology Secures $950,000 Through Private Placement
• Major Sale of Preserve at Melrose Highlights San Diego Appeal
• Landcar Casualty Achieves A Rating Upgrade from AM Best
• Exploring the Surge in Global Mountain Bike Demand by 2028
• NASA's New Contract for Advanced Space Weather Monitoring
• SS&C and Insignia Financial's Strategic Partnership Unveiled
• Exploring the Rush of Athleisure: A Market on the Rise
• Borr Drilling Limited Strengthens Market Position with New Contract
• Promising Phase 1 Results for NX-5948 in CLL/SLL Treatment
• Promising Interim Results for REC-617 Show Potential in Cancer Therapy
• TScan Therapeutics Shares Breakthrough Data in Ongoing Cancer Trial
• Odronextamab Data Reveals Remarkable Efficacy in Lymphoma Trials
• Bitfarms Updates Financial Statements After SEC Review
• Aramis Group Shares Buyback Report and Company Insights
• Innovations Driving the Phone Case Market's Growth through AI